• Pleiotropic sites (E-boxes: lymphoid and myeloid)
• Lineage-specific sites (CEBP sites: myeloid only)
• Pleiotropic sites (E-boxes: lymphoid and myeloid)
• Lineage-specific sites (CEBP sites: myeloid only)
• Complete loss of B cells and pDCs
• Impaired NK cell maturation
• Increased ILC1s and ILC2s
• Increased cDC1 specification and compromised cDC2 development
• Complete loss of B cells and pDCs
• Impaired NK cell maturation
• Increased ILC1s and ILC2s
• Increased cDC1 specification and compromised cDC2 development